About
Clee Medical develops an innovative AI-powered neurosurgical imaging platform, Neuro Access, that uses optical coherence tomography (OCT) to provide real-time, ultra-high-resolution subsurface imaging during brain surgery. This technology aims to improve targeting during stereotactic procedures, addressing anatomical shifts and limited intraoperative visibility to enhance safety and outcomes for patients undergoing complex brain procedures, including functional neurosurgery and neuro-oncology. The platform integrates with existing neurosurgical equipment and provides AI-assisted navigation to interpret live imaging, highlighting key structures and helping avoid critical areas.
Similar companies
Develops innovative surgical technology to make bone surgery safer and more precise by protecting soft tissues.
Shares MedTech, Medical Devices
Develops a brain-computer interface for treating epilepsy.
Shares MedTech, Medical Devices
Develops intravascular lithotripsy technology for treating calcified cardiovascular lesions.
Shares MedTech, Medical Devices
Medical device company developing and commercializing clot removal devices for venous diseases.
Shares MedTech, Medical Devices
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
Shares MedTech, Medical Devices
AI-powered EEG device for rapid seizure detection in critical care.
Shares MedTech, Medical Devices
Key facts
- Website
- clee.medical
- Headquarters
- Geneva, Geneva, Switzerland
- Founded
- 2023
- Employees
- 5
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 26 Feb 2026 | Seed | Undisclosed |
Frequently asked
How many employees does Clee Medical have?
Clee Medical has approximately 5 people on record.
What is Clee Medical's current status?
Clee Medical's current operating status is: Inactive.
